Published by Benjamin Chiou on 17th July 2026
(Sharecast News) - Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic cough drug after unsuccessful results late-stage clinical trial.
URL: http://www.digitallook.com/dl/news/story/36079634/...